Register Interest

Xerion Limited

Xerion is an Australian based specialty pharmaceutical company whose focus is to build a US prescription drug pipeline of 5 new products using AMYCOT® for key dermatological indications. Xerion is currently conducting a $6 million Series A funding round and an IPO is planned in the next 12 months providing early investors a viable exit strategy.